Caseware UK (AP4) 2025.0.111 2025.0.111 2025-10-312025-10-31true2024-11-01falsefalseNo description of principal activity00true 10424447 2024-11-01 2025-10-31 10424447 2023-11-01 2024-10-31 10424447 2025-10-31 10424447 2024-10-31 10424447 c:Director1 2024-11-01 2025-10-31 10424447 d:CurrentFinancialInstruments 2025-10-31 10424447 d:CurrentFinancialInstruments 2024-10-31 10424447 d:ShareCapital 2025-10-31 10424447 d:ShareCapital 2024-10-31 10424447 c:EntityHasNeverTraded 2024-11-01 2025-10-31 10424447 c:FRS102 2024-11-01 2025-10-31 10424447 c:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 10424447 c:FullAccounts 2024-11-01 2025-10-31 10424447 c:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 10424447 e:PoundSterling 2024-11-01 2025-10-31 iso4217:GBP xbrli:pure

Registered number: 10424447









MIDAS GLOBAL MEDICAL SERVICES LTD







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 OCTOBER 2025

 
MIDAS GLOBAL MEDICAL SERVICES LTD
REGISTERED NUMBER: 10424447

BALANCE SHEET
AS AT 31 OCTOBER 2025

2025
2024
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 3 
1
1

  
1
1

Total assets less current liabilities
  
 
 
1
 
 
1

  

Net assets
  
1
1


Capital and reserves
  

Called up share capital 
  
1
1

  
1
1


For the year ended 31 October 2025 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 31 July 2026.



Olusegun Bambgose
Director

The notes on page 2 form part of these financial statements.

Page 1

 
MIDAS GLOBAL MEDICAL SERVICES LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025

1.


General information

The company is limited by shares and incorporated in England. The address of the registerd office is
given in the company information page of these financial statements.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.


3.


Debtors

2025
2024
£
£


Called up share capital not paid
1
1

1
1


Page 2